Monday, February 20, 2017 12:23 AM
CHARENTON-LE-PONT, France—Essilor International
(Reuters: ESSI.PA) posted consolidated revenue of €7,115 million for the year ended Dec. 31, 2016, an increase of 7.6 percent excluding the currency effect.
Friday, February 17, 2017 12:23 AM
LAVAL, Quebec—Valeant Pharmaceuticals International
has entered into an agreement with William Ackman and his Pershing Square Capital Management group that covers the distribution of legal and settlement costs related to a long-running battle with Allergan
shareholders, according to a Securities and Exchange Commission filing
earlier this week.
Wednesday, February 15, 2017 12:21 AM
NEW YORK—Valentine’s Day was not so sweet for the four leading U.S. health plans. The sweeping consolidation of U.S. health plans will not come to fruition, at least in the combos of Aetna/Humana and Cigna/Anthem.
Friday, February 10, 2017 12:23 AM
DUBLIN— Allergan plc
(NYSE: AGN) this week reported financial results showing adjusted revenue of $3.9 billion in the fourth quarter, an increase of 7 percent, which the company attributed to “strong performance” from its facial aesthetics, eyecare and new product launches, among other factors.
Wednesday, February 1, 2017 12:29 AM
MILAN—Luxottica Group S.p.A.
(MTA: LUX; NYSE: LUX) reported consolidated net sales and preliminary results for the fourth quarter and the full fiscal year 2016 here.
Wednesday, February 1, 2017 12:26 AM
(TOKYO:7741) reported a decrease in revenue but an increase in profit for the third quarter ended Dec. 31, 2016.
Wednesday, February 1, 2017 12:23 AM
PADOVA, Italy—Safilo Group S.p.A.
(Reuters SFLG.MI) reported that preliminary figures for fiscal year 2016 showed full year total net sales reached €1,252.8 million, contracting slightly compared to the €1,279.0 million recorded in full year 2015 (down 2.0 percent at current exchange rates and a dip of 1.2 percent at constant exchange rates) as a result of the negative impact of the brands that the Group stopped servicing. In the year, sales of Safilo’s Going Forward Brands Portfolio increased 3.6 percent at constant exchange rates or a gain of 5.2 percent, excluding Retail.
Monday, January 30, 2017 12:23 AM
SCHIPOL, the Netherlands—GrandVision NV
(EURONEXT: GVNV), reported preliminary and unaudited revenue growth at constant exchange rates of 6.6 percent for its fiscal year 2016 and 8.0 percent for the fourth quarter of the year. Comparable growth in the fourth quarter was 3.8 percent while for the full year, the company said comparable growth was 2.2 percent.
Friday, January 27, 2017 12:23 AM
BASEL, Switzerland—With investment in product launches and the loss of patent exclusivity on a key drug weighing on its financial results, Novartis
this week said it managed to deliver “a solid performance” in 2016 with annual sales in line with 2015’s results.
Wednesday, January 25, 2017 7:30 AM
reported Wednesday morning that it is considering various options for its Alcon
eyecare division, which it noted “improved basic operations” in 2016’s fourth quarter.
Wednesday, January 25, 2017 12:23 AM
NEW BRUNSWICK, N.J.—Johnson & Johnson
(NYSE: JNJ) reported Tuesday that its worldwide sales totaled $71.9 billion in fiscal 2016, an increase of 2.6 percent compared to 2015, and its adjusted earnings per share (EPS) totaled $6.73, an increase of 8.5 percent.
Monday, January 16, 2017 12:24 AM
MENLO PARK, Calif.—ForSight VISION4 announced that it has been acquired by Roche Holdings Inc.
Wednesday, January 11, 2017 12:23 AM
SYLMAR, Calif.—Second Sight Medical Products, Inc.
(Nasdaq:EYES) a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, has filed a registration statement on Form S-1 with the Securities and Exchange Commission for a rights offering to its existing stockholders.
Friday, January 6, 2017 12:23 AM
ST. PAUL, Minn.—3M
(NYSE:MMM) announced on Jan. 3 that it has completed the sale of its safety prescription eyewear business to Hoya Vision Care, a division of Hoya Corp (TOKYO: 7741), a global leader in the eyeglass lens industry.